Tue, Jul 22, 2014, 3:06 PM EDT - U.S. Markets close in 54 mins.


% | $
Click the to save as a favorite.

GenMark Diagnostics, Inc. Message Board

  • senior6analyst senior6analyst May 9, 2011 12:28 PM Flag

    Running Out of Cash?

    I like the potential, long-term marketplace of physician office diagnostics that GenMark is aimed at, but at the rate they are losing money, it looks like they will run out of cash before the end of this year?!? Anyone see them progressing far enough with the product that the cash burn rate will drop enough to get their cash into next year without a highly dilutive round of equity?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The next financing round is going to be very very damaging to current shareholders. and i've seen this story before---it's pretty much a guaranteed lock that the upcoming financing round won't be the last. there's a death spiral coming.

      I don't know it's going to take for this company to stop the bleeding and actually have some respectable sales.
      all their competitors are also aggressively moving into the doctor's office. and genmark has pretty much the same tests as everyone else.

      it's neat technology and a respected management team, but i doubt that's enough.

      • 1 Reply to jerrywang99
      • I agree with you Jerry. I noticed that their cash would have dropped approximately another $5 million if they had not gotten a $2 million note, cashed ~$2 million of an "Other Current Asset," and stretched out "Accounts Payable by almost $1 million. When these items come due, the next quarter's cash could drop near $10 million. That means they could run out of cash before the end of this year...?!

10.97-0.05(-0.45%)3:02 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.